Medications

First generic of symbicort receives FDA approval

The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol to treat asthma in patients 6 years and older and for maintenance treatment in ...

Diseases, Conditions, Syndromes

Improving diagnosis of asthma-COPD overlap

A University of Texas at Arlington faculty member and nurse practitioner (NP) said she hopes to bring more attention to an underrecognized condition.

Diseases, Conditions, Syndromes

Ion channel regulates molecule that contributes to COPD

Chronic obstructive pulmonary disease—COPD for short—is one of the most common diseases of the lung. It affects almost 300 million people worldwide, of which about three million die every year. A collective term for chronic ...

Diseases, Conditions, Syndromes

Simple screening for COPD could relieve millions globally

The global burden of Chronic Obstructive Pulmonary Disease (COPD), a group of common lung conditions that affects more than 300 million people, could be significantly reduced with a simple health assessment, concludes a large-scale ...

Medical research

Researchers find new target to combat lung disease

Research led by the Centenary Institute and University of Technology Sydney (UTS) has identified a small RNA molecule called microRNA-21 as a therapeutic target and its inhibition as a potential treatment for chronic obstructive ...

page 7 from 40